PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Rafferty Asset Management, LLC's Holding History (CIK: 0001389426)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 63,661 Value ($000) $5,560 Avg Close $81.85 Range $62.24 - $96.54
Q3 2025
Shares 74,827 Value ($000) $4,971 Avg Close $56.84 Range $49.38 - $68.26
Q2 2025
Shares 80,543 Value ($000) $4,452 Avg Close $47.99 Range $39.60 - $57.70
Q1 2025
Shares 44,257 Value ($000) $2,140 Avg Close $41.90 Range $33.70 - $60.60
Q4 2024
Shares 95,467 Value ($000) $3,685 Avg Close $43.60 Range $33.31 - $48.89
Q3 2024
Shares 89,876 Value ($000) $4,044 Avg Close $40.40 Range $32.50 - $48.00
Q2 2024
Shares 75,270 Value ($000) $2,608 Avg Close $29.29 Range $24.22 - $35.96
Q1 2024
Shares 239,208 Value ($000) $6,920 Avg Close $27.21 Range $21.43 - $33.34
Q4 2023
Shares 167,795 Value ($000) $3,848 Avg Close $17.50 Range $13.72 - $23.88
Q3 2023
Shares 350,281 Value ($000) $5,843 Avg Close $19.40 Range $16.33 - $26.81
Q2 2023
Shares 285,459 Value ($000) $7,884 Avg Close $25.03 Range $17.64 - $30.10
Q1 2023
Shares 153,387 Value ($000) $3,528 Avg Close $16.79 Range $10.62 - $25.69
Q4 2022
Shares 295,348 Value ($000) $3,222 Avg Close $8.44 Range $7.24 - $11.46
Q3 2022
Shares 346,935 Value ($000) $2,925 Avg Close $9.46 Range $7.68 - $11.97
Q2 2022
Shares 314,232 Value ($000) $2,486 Avg Close $12.09 Range $6.91 - $25.76
Q1 2022
Shares 208,094 Value ($000) $4,928 Avg Close $28.17 Range $22.56 - $37.05
Q4 2021
Shares 165,772 Value ($000) $5,669 Avg Close $31.61 Range $17.26 - $38.11
Q3 2021
Shares 69,130 Value ($000) $1,225 Avg Close $42.63 Range $12.80 - $50.54
Q2 2021
Shares 39,192 Value ($000) $1,759 Avg Close $33.01 Range $24.14 - $45.93
Q1 2021
Shares 75,976 Value ($000) $1,968 Avg Close $25.31 Range $18.82 - $32.10
Q4 2020
Shares 13,874 Value ($000) $280 Avg Close $21.52 Range $17.44 - $25.65
Q3 2020
Shares 28,000 Value ($000) $547 Avg Close $18.76 Range $14.16 - $23.25